|
|
T2 Biosystems Announces First Quarter 2021 Financial Results
|
|
|
T2 Biosystems Accelerates Product Development Initiatives Under Existing BARDA Contract
|
|
|
T2 Biosystems Announces Meta-analysis of Controlled Studies in Peer-Reviewed Medical Journal Highlighting the Benefits of T2MR Technology Compared to Blood Culture
|
|
|
T2 Biosystems to Report First Quarter 2021 Financial Results on May 6, 2021
|
|
|
T2 Biosystems CEO Shares Personal Heart Transplant and Sepsis Survival Story in Newly Released Book
|
|
|
T2 Biosystems Reports Granting of Inducement Award
|
|
|
T2 Biosystems Announces Fourth Quarter & Full Year 2020 Financial Results
|
|
|
T2 Biosystems to Report Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
|
|
|
T2 Biosystems to Participate in the BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference
|
|
|
T2 Biosystems T2SARS-CoV-2™ Panel Proves Capable of Detecting the Brazil P.1 Variant of the SARS-CoV-2 Virus
|
